# Omics of Rituximab-resistance

> **NCT07416942** · — · NOT_YET_RECRUITING · sponsor: **Mario Negri Institute for Pharmacological Research** · enrollment: 120 (estimated)

## Conditions studied

- Membranous Nephropathy

## Interventions

- **GENETIC:** Multi-omics Analysis
- **PROCEDURE:** Sample collection

## Key facts

- **NCT ID:** NCT07416942
- **Lead sponsor:** Mario Negri Institute for Pharmacological Research
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2029-03
- **Final completion:** 2029-03
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07416942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07416942, "Omics of Rituximab-resistance". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07416942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*